Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Assets: 2015-2025

Historic Assets for AC Immune (ACIU) over the last 11 years, with Sep 2025 value amounting to $214.5 million.

  • AC Immune's Assets fell 23.91% to $214.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $214.5 million, marking a year-over-year decrease of 23.91%. This contributed to the annual value of $214.5 million for FY2025, which is N/A change from last year.
  • AC Immune's Assets amounted to $214.5 million in FY2025, which was up 81,283.85% from $263,592 recorded in FY2024.
  • AC Immune's Assets' 5-year high stood at $286.1 million during FY2021, with a 5-year trough of $206,096 in FY2023.
  • Over the past 3 years, AC Immune's median Assets value was $263,592 (recorded in 2024), while the average stood at $71.7 million.
  • As far as peak fluctuations go, AC Immune's Assets tumbled by 99.89% in 2023, and later rose by 27.90% in 2024.
  • Yearly analysis of 5 years shows AC Immune's Assets stood at $286.1 million in 2021, then slumped by 32.54% to $193.0 million in 2022, then plummeted by 99.89% to $206,096 in 2023, then rose by 27.90% to $263,592 in 2024, then reached $214.5 million in 2025.